Skip to main content Accessibility help
×
Hostname: page-component-7c8c6479df-r7xzm Total loading time: 0 Render date: 2024-03-28T09:51:10.577Z Has data issue: false hasContentIssue false

Section 5 - Physical and Mental Health Overlap

Published online by Cambridge University Press:  10 March 2021

David Castle
Affiliation:
University of Melbourne
David Coghill
Affiliation:
University of Melbourne
Get access

Summary

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Chapter
Information
Publisher: Cambridge University Press
Print publication year: 2021

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

References

Abutaleb, A., Kattakuzhy, S., Kottilil, S., O’Connor, E., and Wilson, E. 2018. Mechanisms of neuropathogenesis in HIV and HCV: similarities, differences, and unknowns. J Neurovirol, 24(6), 670–8.Google Scholar
Achim, C. L., Adame, A., Dumaop, W., Everall, I. P., Masliah, E., and Neurobehavioral Research, C. 2009. Increased accumulation of intraneuronal amyloid beta in HIV-infected patients. J Neuroimmune Pharmacol, 4(2), 190–9.CrossRefGoogle ScholarPubMed
Alfonso, C. A. and Cohen, M. A. 1997. The role of group therapy in the care of persons with AIDS. J Am Acad Psychoanal, 25(4), 623–38.CrossRefGoogle ScholarPubMed
Alonzo, A. A. and Reynolds, N. R. 1995. Stigma, HIV and AIDS: an exploration and elaboration of a stigma trajectory. Soc Sci Med, 41(3), 303–15.CrossRefGoogle ScholarPubMed
Althoff, K. N., McGinnis, K. A., Wyatt, C. M., et al. 2015. Comparison of risk and age at diagnosis of myocardial infarction, end-stage renal disease, and non-AIDS-defining cancer in HIV-infected versus uninfected adults. Clin Infect Dis, 60(4), 627–38.CrossRefGoogle ScholarPubMed
Altice, F. L., Kamarulzaman, A., Soriano, V. V., Schechter, M., and Friedland, G. H. 2010. Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs. Lancet, 376(9738), 367–87.Google Scholar
Antinori, A., Arendt, G., Becker, J. T., et al. 2007. Updated research nosology for HIV-associated neurocognitive disorders. Neurology, 69(18), 1789–99.CrossRefGoogle ScholarPubMed
Autenrieth, C. S., Beck, E. J., Stelzle, D., Mallouris, C., Mahy, M., and Ghys, P. 2018. Global and regional trends of people living with HIV aged 50 and over: estimates and projections for 2000–2020. PLoS One, 13(11), e0207005.Google Scholar
Balagopal, A., Philp, F. H., Astemborski, J., et al. 2008. Human immunodeficiency virus-related microbial translocation and progression of hepatitis C. Gastroenterology, 135(1), 226–33.CrossRefGoogle ScholarPubMed
Bell, J. E. 1998. The neuropathology of adult HIV infection. Rev Neurol (Paris), 154(12), 816–29.Google ScholarPubMed
Bing, E. G., Kilbourne, A. M., Brooks, R. A., Lazarus, E. F., and Senak, M. 1999. Protease inhibitor use among a community sample of people with HIV disease. J Acquir Immune Defic Syndr Hum Retrovirol, 20(5), 474–80.CrossRefGoogle ScholarPubMed
Blalock, A. C., McDaniel, S. S., J. S. 2005. Anxiety Disorders and HIV Disease. Cambridge: Cambridge University Press.Google Scholar
Blank, M. B., Mandell, D. S., Aiken, L., and Hadley, T. R. 2002. Co-occurrence of HIV and serious mental illness among Medicaid recipients. Psychiatr Serv, 53(7), 868–73.Google Scholar
Brenneman, D. E., Westbrook, G. L., Fitzgerald, S. P., Ennist, D. L., Elkins, K. L., Ruff, M. R., and Pert, C. B. 1988. Neuronal cell killing by the envelope protein of HIV and its prevention by vasoactive intestinal peptide. Nature, 335(6191), 639–42.Google Scholar
Brew, B. J. and Garber, J. Y. 2018. Neurologic sequelae of primary HIV infection. In: Brew, B. J. (ed.), Handbook of Clinical Neurology, vol. 152. Cambridge, MA: Elsevier, pp. 6574.Google Scholar
Buch, S., Yao, H., Guo, M., Mori, T., Su, T. P., and Wang, J. 2011. Cocaine and HIV-1 interplay: molecular mechanisms of action and addiction. J Neuroimmune Pharmacol, 6(4), 503–15.Google Scholar
Cabral, G. A. and Staab, A. 2005. Effects on the immune system. Handb Exp Pharmacol, 168, 385423.Google Scholar
Centers for Disease Control and Prevention. 2000. HIV/AIDS Surveillance Report: US HIV and AIDS cases reported through December 1999. Centers for Disease Control and Prevention. https://ci.nii.ac.jp/naid/10010139231/Google Scholar
Chana, G., Everall, I. P., Crews, L., et al. 2006. Cognitive deficits and degeneration of interneurons in HIV+ methamphetamine users. Neurology, 67(8), 1486–9.CrossRefGoogle ScholarPubMed
Chang, L., Ernst, T., Speck, O., and Grob, C. S. 2005. Additive effects of HIV and chronic methamphetamine use on brain metabolite abnormalities. Am J Psychiatry, 162(2), 361–9.Google Scholar
Chaudhury, S., Bakhla, A., and Saini, R. 2016. Prevalence, impact, and management of depression and anxiety in patients with HIV: a review. Neurobehavioral HIV Medicine, 7, 1530.CrossRefGoogle Scholar
Chesney, M. A., Barrett, D. C., and Stall, R. 1998. Histories of substance use and risk behavior: precursors to HIV seroconversion in homosexual men. Am J Public Health, 88(1), 113–16.CrossRefGoogle ScholarPubMed
Childs, E. A., Lyles, R. H., Selnes, O. A., et al. 1999. Plasma viral load and CD4 lymphocytes predict HIV-associated dementia and sensory neuropathy. Neurology, 52(3), 607–13.Google Scholar
Choi, S. K., Boyle, E., Cairney, J., Collins, E. J., Gardner, S., Bacon, J., and Rourke, S. B. 2016. Prevalence, recurrence, and incidence of current depressive symptoms among people living with HIV in Ontario, Canada: results from the Ontario HIV Treatment Network Cohort Study. PLoS One, 11(11), e0165816.CrossRefGoogle ScholarPubMed
Clifford, D. B. and Ances, B. M. 2013. HIV-associated neurocognitive disorder. Lancet Infect Dis, 13(11), 976–86.Google Scholar
Cohen, M. A. et al. (eds.). 2017. Comprehensive Textbook of AIDS Psychiatry: A Paradigm for Integrated Care, 2nd Edition. Oxford: Oxford University Press.CrossRefGoogle Scholar
Cosenza, M. A., Zhao, M. L., Si, Q., and Lee, S. C. 2002. Human brain parenchymal microglia express CD14 and CD45 and are productively infected by HIV-1 in HIV-1 encephalitis. Brain Pathol, 12(4), 442–55.Google Scholar
Cristiani, S. A., Pukay-Martin, N. D., and Bornstein, R. A. 2004. Marijuana use and cognitive function in HIV-infected people. J Neuropsychiatry Clin Neurosci, 16(3), 330–5.CrossRefGoogle ScholarPubMed
David, A. S. et al. 2012. Lishman’s Organic Psychiatry: A Textbook of Neuropsychiatry, Fourth Edition. Oxford: Wiley-Blackwell.Google Scholar
Davis, L. E., Hjelle, B. L., Miller, V. E., et al. 1992. Early viral brain invasion in iatrogenic human immunodeficiency virus infection. Neurology, 42(9), 1736–9.CrossRefGoogle ScholarPubMed
De Ronchi, D., Faranca, I., Berardi, D., Scudellari, P., Borderi, M., Manfredi, R., and Fratiglioni, L. 2002. Risk factors for cognitive impairment in HIV-1-infected persons with different risk behaviors. Arch Neurol, 59(5), 812–18.CrossRefGoogle ScholarPubMed
Deeks, S. G., Tracy, R., and Douek, D. C. 2013. Systemic effects of inflammation on health during chronic HIV infection. Immunity, 39(4), 633–45.CrossRefGoogle Scholar
Des Jarlais, D. C., Friedman, S. R., Novick, D. M., et al. 1989. HIV-1 infection among intravenous drug users in Manhattan, New York City, from 1977 through 1987. JAMA, 261(7), 1008–12.Google Scholar
Dew, M. A., Becker, J. T., Sanchez, J., et al. 1997. Prevalence and predictors of depressive, anxiety and substance use disorders in HIV-infected and uninfected men: a longitudinal evaluation. Psychol Med, 27(2), 395409.Google Scholar
Durvasula, R. and Miller, T. R. 2014. Substance abuse treatment in persons with HIV/AIDS: challenges in managing triple diagnosis. Behav Med, 40(2), 4352.Google Scholar
Durvasula, R. S., Myers, H. F., Mason, K., and Hinkin, C. 2006. Relationship between alcohol use/abuse, HIV infection and neuropsychological performance in African American men. J Clin Exp Neuropsychol, 28(3), 383404.Google Scholar
Eggers, C., Arendt, G., Hahn, K., et al. 2017. HIV-1-associated neurocognitive disorder: epidemiology, pathogenesis, diagnosis, and treatment. J Neurol, 264(8), 1715–27.Google Scholar
Eisenstein, T. K., Rahim, R. T., Feng, P., Thingalaya, N. K., and Meissler, J. J. 2006. Effects of opioid tolerance and withdrawal on the immune system. J Neuroimmune Pharmacol, 1(3), 237–49.CrossRefGoogle ScholarPubMed
Ellis, R. J., Childers, M. E., Cherner, M., Lazzaretto, D., Letendre, S., Grant, I., and Group, H. I. V. N. R. C. 2003. Increased human immunodeficiency virus loads in active methamphetamine users are explained by reduced effectiveness of antiretroviral therapy. J Infect Dis, 188(12), 1820–6.Google Scholar
Etherton, M. R., Lyons, J. L., and Ard, K. L. 2015. HIV-associated neurocognitive disorders and antiretroviral therapy: current concepts and controversies. Curr Infect Dis Rep, 17(6), 485.Google Scholar
European AIDS Clinical Society. 2017. European AIDS Clinical Society guidelines, v9.0. https://doi.org/10.1111/hiv.12878Google Scholar
Everall, I., Barnes, H., Spargo, E., and Lantos, P. 1995. Assessment of neuronal density in the putamen in human immunodeficiency virus (HIV) infection. Application of stereology and spatial analysis of quadrats. J Neurovirol, 1(1), 126–9.Google Scholar
Everall, I., Salaria, S., Roberts, E., et al. 2005. Methamphetamine stimulates interferon inducible genes in HIV infected brain. J Neuroimmunol, 170(1–2), 158–71.Google Scholar
Everall, I. P., Heaton, R. K., Marcotte, T. D., et al. 1999. Cortical synaptic density is reduced in mild to moderate human immunodeficiency virus neurocognitive disorder. HNRC Group. HIV Neurobehavioral Research Center. Brain Pathol, 9(2), 209–17.CrossRefGoogle Scholar
Fauci, A. S. 1996. Host factors and the pathogenesis of HIV-induced disease. Nature, 384(6609), 529–34.CrossRefGoogle ScholarPubMed
Ferrando, S. J., and Batki, S. L. 2000. Substance abuse and HIV infection. New Dir Ment Health Serv, 87, 57–67.Google Scholar
Fiala, M., Gan, X. H., Zhang, L., et al. 1998. Cocaine enhances monocyte migration across the blood–brain barrier. Cocaine’s connection to AIDS dementia and vasculitis? Adv Exp Med Biol, 437, 199205.CrossRefGoogle ScholarPubMed
Gaida, R., Truter, I., Grobler, C., Kotze, T., and Godman, B. 2016. A review of trials investigating efavirenz-induced neuropsychiatric side effects and the implications. Expert Rev Anti Infect Ther, 14(4), 377–88.Google Scholar
Gandhi, N. S., Moxley, R. T., Creighton, J., et al. 2010. Comparison of scales to evaluate the progression of HIV-associated neurocognitive disorder. HIV Ther, 4(3), 371–9.Google ScholarPubMed
Gannon, P., Khan, M. Z., and Kolson, D. L. 2011. Current understanding of HIV-associated neurocognitive disorders pathogenesis. Curr Opin Neurol, 24(3), 275–83.CrossRefGoogle ScholarPubMed
Gardner, B., Zhu, L. X., Roth, M. D., Tashkin, D. P., Dubinett, S. M., and Sharma, S. 2004. Cocaine modulates cytokine and enhances tumor growth through sigma receptors. J Neuroimmunol, 147(1–2), 95–8.Google Scholar
Gendelman, H. E. (eds.). 2012. The Neurology of AIDS, 3rd Edition. Oxford: Oxford University Press.Google Scholar
Ghosn, J., Taiwo, B., Seedat, S., Autran, B., and Katlama, C. 2018. Hiv. Lancet, 392(10148), 685–97.Google Scholar
Giometto, B., An, S. F., Groves, M., et al. 1997. Accumulation of beta-amyloid precursor protein in HIV encephalitis: relationship with neuropsychological abnormalities. Ann Neurol, 42(1), 3440.Google Scholar
Gonzalez-Scarano, F. and Martin-Garcia, J. 2005. The neuropathogenesis of AIDS. Nat Rev Immunol, 5(1), 6981.CrossRefGoogle ScholarPubMed
Gonzalez-Serna, A., Ajaykumar, A., Gadawski, I., Munoz-Fernandez, M. A., Hayashi, K., Harrigan, P. R., and Cote, H. C. F. 2017. Rapid decrease in peripheral blood mononucleated cell telomere length after HIV seroconversion, but not HCV seroconversion. J Acquir Immune Defic Syndr, 76(1), e29e32.Google Scholar
Gostner, J. M., Becker, K., Kurz, K., and Fuchs, D. 2015. Disturbed amino acid metabolism in HIV: association with neuropsychiatric symptoms. Front Psychiatry, 6, 97.Google Scholar
Gras, G. and Kaul, M. 2010. Molecular mechanisms of neuroinvasion by monocytes-macrophages in HIV-1 infection. Retrovirology, 7, 30.Google Scholar
Gurwell, J. A., Nath, A., Sun, Q., Zhang, J., Martin, K. M., Chen, Y., and Hauser, K. F. 2001. Synergistic neurotoxicity of opioids and human immunodeficiency virus-1 Tat protein in striatal neurons in vitro. Neuroscience, 102(3), 555–63.Google Scholar
Hahn, J. A., and Samet, J. H. 2010. Alcohol and HIV disease progression: weighing the evidence. Curr HIV/AIDS Rep, 7(4), 226–33.Google Scholar
Hauser, S. L. (ed.) 2013. Harrison’s Neurology in Clinical Practice, 3rd Edition. Sydney: McGraw Hill Education.Google Scholar
Hays, R. D., Cunningham, W. E., Sherbourne, C. D., et al. 2000. Health-related quality of life in patients with human immunodeficiency virus infection in the United States: results from the HIV Cost and Services Utilization Study. Am J Med, 108(9), 714–22.Google Scholar
Heaton, R. K., Clifford, D. B., Franklin, D. R. Jr., et al. 2010. HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology, 75(23), 2087–96.CrossRefGoogle ScholarPubMed
Heaton, R. K., Franklin, D. R., Ellis, R. J., et al. 2011. HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J Neurovirol, 17(1), 316.Google Scholar
Hinkin, C. H., Castellon, S. A., Atkinson, J. H., and Goodkin, K. 2001. Neuropsychiatric aspects of HIV infection among older adults. J Clin Epidemiol, 54 Suppl 1, S44–52.CrossRefGoogle ScholarPubMed
Huang, X., Meyers, K., Liu, X., et al. 2018. The double burdens of mental health among AIDS patients with fully successful immune restoration: a cross-sectional study of anxiety and depression in China. Front Psychiatry, 9, 384.Google Scholar
Hult, B., Chana, G., Masliah, E., and Everall, I. 2008. Neurobiology of HIV. Int Rev Psychiatry, 20(1), 313.CrossRefGoogle ScholarPubMed
Hurt, C. B., Torrone, E., Green, K., Foust, E., Leone, P., and Hightow-Weidman, L. 2010. Methamphetamine use among newly diagnosed HIV-positive young men in North Carolina, United States, from 2000 to 2005. PLoS One, 5(6), e11314.Google Scholar
Jacobs, E. S., Keating, S. M., Abdel-Mohsen, M., et al. 2017. Cytokines elevated in HIV elite controllers reduce HIV replication in vitro and modulate HIV restriction factor expression. J Virol, 91(6).Google Scholar
Jernigan, T. L., Gamst, A. C., Archibald, S. L., et al. 2005. Effects of methamphetamine dependence and HIV infection on cerebral morphology. Am J Psychiatry, 162(8), 1461–72.Google Scholar
Justice, A. C., McGinnis, K. A., Atkinson, J. H., et al. 2004. Psychiatric and neurocognitive disorders among HIV-positive and negative veterans in care: Veterans Aging Cohort Five-Site Study. AIDS, 18 Suppl 1, S49–59.CrossRefGoogle ScholarPubMed
Kaul, M. and Lipton, S. A. 2006. Mechanisms of neuroimmunity and neurodegeneration associated with HIV-1 infection and AIDS. J Neuroimmune Pharmacol, 1(2), 138–51.Google Scholar
Kelley, K. W., Bluthe, R. M., Dantzer, R., Zhou, J. H., Shen, W. H., Johnson, R. W., and Broussard, S. R. 2003. Cytokine-induced sickness behavior. Brain Behav Immun, 17 Suppl 1, S112–18.Google Scholar
Kessler, R. C., McGonagle, K. A., Zhao, S., et al. 1994. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry, 51(1), 819.Google Scholar
Khanlou, N., Moore, D. J., Chana, G., et al. 2009. Increased frequency of alpha-synuclein in the substantia nigra in human immunodeficiency virus infection. J Neurovirol, 15(2), 131–8.CrossRefGoogle ScholarPubMed
Kooij, K. W., Wit, F. W., Schouten, J., et al. 2016. HIV infection is independently associated with frailty in middle-aged HIV type 1-infected individuals compared with similar but uninfected controls. AIDS, 30(2), 241–50.Google Scholar
Letendre, S. L., Woods, S. P., Ellis, R. J., et al. 2006. Lithium improves HIV-associated neurocognitive impairment. AIDS, 20(14), 1885–8.Google Scholar
Levy, R. M. and Bredesen, D. E. 1988. Central nervous system dysfunction in acquired immunodeficiency syndrome. J Acquir Immune Defic Syndr, 1(1), 4164.Google Scholar
Levy, R. M., Rosenbloom, S., and Perrett, L. V. 1986. Neuroradiologic findings in AIDS: a review of 200 cases. AJR Am J Roentgenol, 147(5), 977–83.Google Scholar
Li, J., Mo, P. K., Wu, A. M., and Lau, J. T. 2017. Roles of self-stigma, social support, and positive and negative affects as determinants of depressive symptoms among HIV infected men who have sex with men in China. AIDS Behav, 21(1), 261–73.CrossRefGoogle ScholarPubMed
Lyketsos, C. G., Hutton, H., Fishman, M., Schwartz, J., and Treisman, G. J. 1996. Psychiatric morbidity on entry to an HIV primary care clinic. AIDS, 10(9), 1033–9.Google Scholar
Manji, H. and Miller, R. 2004. The neurology of HIV infection. J Neurol Neurosurg Psychiatry, 75 (suppl. 1), i29–35.Google Scholar
Marcondes, M. C., Flynn, C., Watry, D. D., Zandonatti, M., and Fox, H. S. 2010. Methamphetamine increases brain viral load and activates natural killer cells in simian immunodeficiency virus-infected monkeys. Am J Pathol, 177(1), 355–61.Google Scholar
Masliah, E., Roberts, E. S., Langford, D., et al. 2004. Patterns of gene dysregulation in the frontal cortex of patients with HIV encephalitis. J Neuroimmunol, 157(1–2), 163–75.Google Scholar
McArthur, J. C., Hoover, D. R., Bacellar, H., et al. 1993. Dementia in AIDS patients: incidence and risk factors. Multicenter AIDS Cohort Study. Neurology, 43(11), 2245–52.Google Scholar
McArthur, J. C., McClernon, D. R., Cronin, M. F., Nance-Sproson, T. E., Saah, A. J., St Clair, M., and Lanier, E. R. 1997. Relationship between human immunodeficiency virus-associated dementia and viral load in cerebrospinal fluid and brain. Ann Neurol, 42(5), 689–98.Google Scholar
McCoy, C. B., Metsch, L. R., Chitwood, D. D., Shapshak, P., and Comerford, S. T. 1998. Parenteral transmission of HIV among injection drug users: assessing the frequency of multiperson use of needles, syringes, cookers, cotton, and water. J Acquir Immune Defic Syndr Hum Retrovirol, 18 (suppl. 1), S25–9.Google Scholar
McGuire, J. L., Kempen, J. H., Localio, R., Ellenberg, J. H., and Douglas, S. D. 2015. Immune markers predictive of neuropsychiatric symptoms in HIV-infected youth. Clin Vaccine Immunol, 22(1), 2736.Google Scholar
Meltzer, M. S., Skillman, D. R., Gomatos, P. J., Kalter, D. C., and Gendelman, H. E. 1990. Role of mononuclear phagocytes in the pathogenesis of human immunodeficiency virus infection. Annu Rev Immunol, 8, 169–94.Google Scholar
Mental Health Foundation. 2016. Survey of people with lived experience of mental health problems reveals men less likely to seek medical support. www.mentalhealth.org.uk/news/survey-people-lived-experience-mental-health-problems-reveals-men-less-likely-seek-medical.Google Scholar
Morrison, M. F., Petitto, J. M., Ten Have, T., et al. 2002. Depressive and anxiety disorders in women with HIV infection. Am J Psychiatry, 159(5), 789–96.Google Scholar
New, D. R., Ma, M., Epstein, L. G., Nath, A., and Gelbard, H. A. 1997. Human immunodeficiency virus type 1 Tat protein induces death by apoptosis in primary human neuron cultures. J Neurovirol, 3(2), 168–73.Google Scholar
NICE. 2011. NICE Clinical Guidance (CG113) – Generalised anxiety disorder and panic disorder in adults: management. www.nice.org.uk/guidance/cg113Google Scholar
NICE. 2018. NICE Clinical Guidance (CG90) – Depression in adults: recognition and management. www.nice.org.uk/guidance/cg90Google Scholar
Nightingale, S., Winston, A., Letendre, S., Michael, B. D., McArthur, J. C., Khoo, S., and Solomon, T. 2014. Controversies in HIV-associated neurocognitive disorders. Lancet Neurol, 13(11), 1139–51.Google Scholar
Oliver, M. I., Pearson, N., Coe, N., and Gunnell, D. 2005. Help-seeking behaviour in men and women with common mental health problems: cross-sectional study. Br J Psychiatry, 186, 297301.Google Scholar
Parsons, J. T., Rosof, E., Punzalan, J. C., and Di Maria, L. 2005. Integration of motivational interviewing and cognitive behavioral therapy to improve HIV medication adherence and reduce substance use among HIV-positive men and women: results of a pilot project. AIDS Patient Care STDS, 19(1), 31–9.Google Scholar
Parsons, T. D., Tucker, K. A., Hall, C. D., Robertson, W. T., Eron, J. J., Fried, M. W., and Robertson, K. R. 2006. Neurocognitive functioning and HAART in HIV and hepatitis C virus co-infection. AIDS, 20(12), 1591–5.Google Scholar
Peterson, P. K., Gekker, G., Chao, C. C., et al. 1992. Cocaine amplifies HIV-1 replication in cytomegalovirus-stimulated peripheral blood mononuclear cell cocultures. J Immunol, 149(2), 676–80.CrossRefGoogle ScholarPubMed
Peterson, P. K., Gekker, G., Hu, S., et al. 1994. Morphine amplifies HIV-1 expression in chronically infected promonocytes cocultured with human brain cells. J Neuroimmunol, 50(2), 167–75.Google Scholar
Petito, C. K., Roberts, B., Cantando, J. D., Rabinstein, A., and Duncan, R. 2001. Hippocampal injury and alterations in neuronal chemokine co-receptor expression in patients with AIDS. J Neuropathol Exp Neurol, 60(4), 377–85.Google Scholar
Plankey, M. W., Ostrow, D. G., Stall, R., Cox, C., Li, X., Peck, J. A., and Jacobson, L. P. 2007. The relationship between methamphetamine and popper use and risk of HIV seroconversion in the multicenter AIDS cohort study. J Acquir Immune Defic Syndr, 45(1), 8592.Google Scholar
Price, T. O., Uras, F., Banks, W. A., and Ercal, N. 2006. A novel antioxidant N-acetylcysteine amide prevents gp120- and Tat-induced oxidative stress in brain endothelial cells. Exp Neurol, 201(1), 193202.Google Scholar
Reback, C. J., Larkins, S., and Shoptaw, S. 2003. Methamphetamine abuse as a barrier to HIV medication adherence among gay and bisexual men. AIDS Care, 15(6), 775–85.Google Scholar
Reddy, P. V., Pilakka-Kanthikeel, S., Saxena, S. K., Saiyed, Z., and Nair, M. P. 2012. Interactive effects of morphine on HIV infection: role in HIV-associated neurocognitive disorder. AIDS Res Treat, 2012article ID: 953678, 10pp.Google Scholar
Resnick, L., Berger, J. R., Shapshak, P., and Tourtellotte, W. W. 1988. Early penetration of the blood–brain-barrier by HIV. Neurology, 38(1), 914.Google Scholar
Reynolds, J. L., Mahajan, S. D., Bindukumar, B., Sykes, D., Schwartz, S. A., and Nair, M. P. 2006. Proteomic analysis of the effects of cocaine on the enhancement of HIV-1 replication in normal human astrocytes (NHA). Brain Res, 1123(1), 226–36.Google Scholar
Rippeth, J. D., Heaton, R. K., Carey, C. L., et al. 2004. Methamphetamine dependence increases risk of neuropsychological impairment in HIV infected persons. J Int Neuropsychol Soc, 10(1), 114.Google Scholar
Robin, S. L. and Kumar, V. 2010. Robbins and Cotran Pathological Basis of Disease, 8th Edition. Philadelphia, PA: Saunders Elsevier.Google Scholar
Rosca, E. C., Rosca, O., Simu, M., and Chirileanu, R. D. 2012. HIV-associated neurocognitive disorders: a historical review. Neurologist, 18(2), 64–7.Google Scholar
Roy, S., Ramakrishnan, S., Loh, H. H., and Lee, N. M. 1991. Chronic morphine treatment selectively suppresses macrophage colony formation in bone marrow. Eur J Pharmacol, 195(3), 359–63.CrossRefGoogle ScholarPubMed
Sanmarti, M., Ibanez, L., Huertas, S., et al. 2014. HIV-associated neurocognitive disorders. J Mol Psychiatry, 2(1), 2.Google Scholar
Saylor, D., Dickens, A. M., Sacktor, N., et al. 2016. HIV-associated neurocognitive disorder – pathogenesis and prospects for treatment. Nat Rev Neurol, 12(5), 309.Google Scholar
Schroecksnadel, K., Sarcletti, M., Winkler, C., et al. 2008. Quality of life and immune activation in patients with HIV-infection. Brain Behav Immun, 22(6), 881–9.Google Scholar
Scott, J. C., Woods, S. P., Carey, C. L., Weber, E., Bondi, M. W., Grant, I., and Group, H. I. V. N. R. C. 2011. Neurocognitive consequences of HIV infection in older adults: an evaluation of the ‘cortical’ hypothesis. AIDS Behav, 15(6), 1187–96.Google Scholar
Scott-Sheldon, L. A., Carey, K. B., Cunningham, K., Johnson, B. T., Carey, M. P., and Team, M. R. 2016. Alcohol use predicts sexual decision-making: a systematic review and meta-analysis of the experimental literature. AIDS Behav, 20 (suppl. 1), S19–39.Google Scholar
Sewell, M. C., Goggin, K. J., Rabkin, J. G., Ferrando, S. J., McElhiney, M. C., and Evans, S. 2000. Anxiety syndromes and symptoms among men with AIDS: a longitudinal controlled study. Psychosomatics, 41(4), 294300.Google Scholar
Sharp, P. M. and Hahn, B. H. 2011. Origins of HIV and the AIDS pandemic. Cold Spring Harb Perspect Med, 1(1), a006841.Google Scholar
Simioni, S., Cavassini, M., Annoni, J. M., et al. 2013. Rivastigmine for HIV-associated neurocognitive disorders: a randomized crossover pilot study. Neurology, 80(6), 553–60.Google Scholar
Simoni, J. M., Safren, S. A., Manhart, L. E., et al. 2011. Challenges in addressing depression in HIV research: assessment, cultural context, and methods. AIDS Behav, 15(2), 376–88.Google Scholar
Sin, N. L. and DiMatteo, M. R. 2014. Depression treatment enhances adherence to antiretroviral therapy: a meta-analysis. Ann Behav Med, 47(3), 259–69.Google Scholar
Snider, W. D., Simpson, D. M., Nielsen, S., Gold, J. W., Metroka, C. E., and Posner, J. B. 1983. Neurological complications of acquired immune deficiency syndrome: analysis of 50 patients. Ann Neurol, 14(4), 403–18.Google Scholar
Spencer, S. J., Emmerzaal, T. L., Kozicz, T., and Andrews, Z. B. 2015. Ghrelin’s role in the hypothalamic–pituitary–adrenal axis stress response: implications for mood disorders. Biol Psychiatry, 78(1), 1927.Google Scholar
Steele, A. D., Henderson, E. E., and Rogers, T. J. 2003. Mu-opioid modulation of HIV-1 coreceptor expression and HIV-1 replication. Virology, 309(1), 99107.Google Scholar
Stern, Y., McDermott, M. P., Albert, S., et al. 2001. Factors associated with incident human immunodeficiency virus-dementia. Arch Neurol, 58(3), 473–9.Google Scholar
Strodl, E., Stewart, L., Mullens, A. B., and Deb, S. 2015. Metacognitions mediate HIV stigma and depression/anxiety in men who have sex with men living with HIV. Health Psychol Open, 2(1), 2055102915581562.Google Scholar
Szabo, I., Rojavin, M., Bussiere, J. L., Eisenstein, T. K., Adler, M. W., and Rogers, T. J. 1993. Suppression of peritoneal macrophage phagocytosis of Candida albicans by opioids. J Pharmacol Exp Ther, 267(2), 703–6.Google ScholarPubMed
Taylor, D., Barnes, T., and Young, A. H. 2018. The Maudsley Prescribing Guidelines in Psychiatry, 13th Edition. New York: Wiley-Blackwell.Google Scholar
Tierney, S., Woods, S. P., Verduzco, M., Beltran, J., Massman, P. J., and Hasbun, R. 2018. Semantic memory in HIV-associated neurocognitive disorders: an evaluation of the ‘cortical’ versus ‘subcortical’ hypothesis. Arch Clin Neuropsychol, 33(4), 406–16.CrossRefGoogle ScholarPubMed
Turjanski, N. L. G. G. 2005. Psychiatric side-effects of medications: recent developments. Advances in Psychiatric Treatment, 11, 5870.CrossRefGoogle Scholar
Turner, K. J., Vasu, V., and Griffin, D. K. 2019. Telomere biology and human phenotype. Cells, 8(1).Google Scholar
UNAIDS (The United Nations Joint Programme of HIV/AIDS). 2018. Report on the global HIV/AIDS epidemic, June 1998. Geneva: UNAIDS.Google Scholar
University of Liverpool. 2019. HIV drug interactions, antidepressants. www.hiv-druginteractions.org/prescribing-resources.Google Scholar
Vagenas, P., Azar, M. M., Copenhaver, M. M., Springer, S. A., Molina, P. E., and Altice, F. L. 2015. The impact of alcohol use and related disorders on the HIV continuum of care: a systematic review : alcohol and the HIV continuum of care. Curr HIV/AIDS Rep, 12(4), 421–36.Google Scholar
Watzl, B. and Watson, R. R. 1992. Role of alcohol abuse in nutritional immunosuppression. J Nutr, 122 (suppl. 3), 733–7.Google Scholar
WHO. 2008. HIV/AIDS and mental health. Geneva: World Health Organization.Google Scholar
Winston, A., Duncombe, C., Li, P. C., et al. 2010. Does choice of combination antiretroviral therapy (cART) alter changes in cerebral function testing after 48 weeks in treatment-naive, HIV-1-infected individuals commencing cART? A randomized, controlled study. Clin Infect Dis, 50(6), 920–9.Google Scholar
Wu, E. S., Metzger, D. S., Lynch, K. G., and Douglas, S. D. 2011. Association between alcohol use and HIV viral load. J Acquir Immune Defic Syndr, 56(5), e129–30.Google Scholar
Yeager, M. P., Colacchio, T. A., Yu, C. T., Hildebrandt, L., Howell, A. L., Weiss, J., and Guyre, P. M. 1995. Morphine inhibits spontaneous and cytokine-enhanced natural killer cell cytotoxicity in volunteers. Anesthesiology, 83(3), 500–8.Google Scholar
Zahr, N. M. 2018. The aging brain with HIV infection: effects of alcoholism or hepatitis C comorbidity. Front Aging Neurosci, 10, 56.Google Scholar
Zanet, D. L., Thorne, A., Singer, J., et al. 2014. Association between short leukocyte telomere length and HIV infection in a cohort study: no evidence of a relationship with antiretroviral therapy. Clin Infect Dis, 58(9), 1322–32.Google Scholar

References

Armstrong, N. M., Meoni, L. A., Carlson, M. C., et al. 2014. Cardiovascular risk factors and risk of incident depression throughout adulthood among men: the Johns Hopkins Precursors Study. Journal of Affective Disorders, 214, 60–6.Google Scholar
Arnberg, F. K., Linton, S. J., Hultcrantz, M., et al. 2014. Internet-delivered psychological treatments for mood and anxiety disorders: a systematic review of their efficacy, safety, and cost-effectiveness. PLoS One, 9(5), e98118Google Scholar
Benjamin, E. J., Virani, S. S., Callaway, C. W., et al. 2018. Heart disease and stroke statistics – 2018 update: a report from the American Heart Association. Circulation, 137, e67e492.Google Scholar
Blumberg, S. J., Clarke, T. C., and Blackwell, D. L. 2015. Racial and Ethnic Disparities in Men’s Use of Mental Health Treatments. NCHS Data Brief, no 206. Hyattsville, MD: National Center for Health Statistics.Google Scholar
Brown, A., Mentha, R., Howard, M., et al. 2016. Men, heart and minds: developing and piloting culturally specific psychometric tools assessing psychosocial stress and depression in central Australian Aboriginal men. Social Psychiatry and Psychiatric Epidemiology, 51, 211–23.Google Scholar
Caperchione, C. M., Bottorff, J. L., Oliffe, J. L., et al. 2017. The HAT TRICK programme for improving physical activity, healthy eating and connectedness among overweight, inactive men: study protocol of a pragmatic feasibility trial. BMJ Open, 7, e016940.Google Scholar
Celano, C.M., Daunis, D.J., Lokko, H.N., et al. 2016. Anxiety disorders and cardiovascular disease. Current Psychiatry Reports, 18(11), 101.Google Scholar
Chaddha, A., Robinson, E. A., Kline-Rogers, E., et al. 2016. Mental health and cardiovascular disease. American Journal of Medicine, 129, 1145–8.Google Scholar
Clarke, L. H. and Bennett, E. 2013. ‘You learn to live with all the things that are wrong with you’: gender and the experience of multiple chronic conditions in later life. Ageing and Society, 33, 342–60.Google Scholar
Cohen, B. E., Edmondon, D., and Kronish, I. M. 2015. State of the art review: depression, stress, anxiety, and cardiovascular disease. American Journal of Hypertension, 28, 12951302.Google Scholar
Correll, C. U., Solmi, M., Veronese, N., et al. 2017. Prevalence, incidence and mortality from cardiovascular disease in patients with pooled and specific severe mental illness: a large-scale meta-analysis of 3,211,768 patients and 1112,383,368 controls. World Psychiatry, 16, 163–80.Google Scholar
Davidson, K. W., Bigger, J. T., Burg, M. M., et al. 2013. Centralized, stepped, patient preference-based treatments for patients with post-acute coronary syndrome depression: CODIACS Vanguard randomized controlled trial. JAMA Internal Medicine, 173, 9971004.Google Scholar
Dhar, A. K. and Barton, D. A. 2016. Depression and the link with cardiovascular disease. Frontiers in Psychiatry, 7, 33.Google Scholar
Ellis, L. A., Collin, P., Hurley, P. J., et al. 2013. Young men’s attitudes and behaviour in relation to mental health and technology: implications for the development of online mental health services. BMC Psychiatry, 13, 119.Google Scholar
Engberg, E., Liira, H., Kukkonen-Harjula, K., et al. 2017. The effects of health counselling and exercise training on self-rated health and well-being in middle-aged men: a randomized trial. Journal of Sports Medicine and Physical Fitness, 57, 916–22.Google Scholar
Firth, J., Rosenbaum, S., Stubbs, B., et al. 2016. Motivating factors and barriers towards exercise in severe mental illness: a systematic review and meta-analysis. Psychological Medicine, 46, 2869–81.Google Scholar
Fogarty, A. S., Proudfoot, J., Whittle, E. L., et al. 2015. Men’s use of positive strategies for presenting and managing depression: a qualitative investigation. Journal of Affective Disorders, 188, 179–87.Google Scholar
Galletly, C., Castle, D., Dark, F., et al. 2016. Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the management of schizophrenia and related disorders. Australian and New Zealand Journal of Psychiatry, 50, 410–72.Google Scholar
Garbers, S., Hunersen, K., Nechiltilo, M, et al. 2018. Healthy weight and cardiovascular health promotion interventions for adolescent and adult young males of color: a systematic review. American Journal of Men’s Health, 12, 1328–51.Google Scholar
Gozdik, A., Salehi, R., O’Campo, P., et al. 2015. Cardiovascular risk factors and 30-year in homeless adults with mental illness. BMC Public Health, 15, 165.Google Scholar
Hallahan, B., Ryan, T., Hibbeln, J. R., et al. 2016. Efficacy of omega-3 highly unsaturated fatty acids in the treatment of depression. British Journal of Psychiatry, 209, 192201.Google Scholar
Hare, D.L., Toukhasti, S.R., Johansson, P., et al. 2014. Depression and cardiovascular disease: a clinical review. European Heart Journal, 35, 1365–72.Google Scholar
Hibbeln, J. R., Northstone, K., Evans, J., et al. 2018. Vegetarian diets and depressive symptoms among men. Journal of Affective Disorders, 225, 1317.Google Scholar
Huffman, J. C., Mastromauro, C. A., Beach, S. R., et al. 2014. Collaborative care for depression and anxiety disorders in patients with recent cardiac events: the Management of sadness and Anxiety in Cardiology (MOSAIC) randomized clinical trial. JAMA Internal Medicine, 174, 927–35.Google Scholar
Jandackova, V. K., Britton, A., Malik, M., et al. 2016. Heart rate variability and depressive symptoms: a cross-lagged analysis over a 10-year period in the Whitehall II study. Psychological Medicine, 46, 2121–31.CrossRefGoogle Scholar
Johnson, J. L., Oliffe, J. L., Kelly, M. T., et al. 2012. Men’s discourses of help-seeking in the context of depression. Sociology, Health and Illness, 34, 345–61.Google Scholar
Keohane, A. and Richardson, N. 2018. Negotiating gender norms to support men in psychological distress. American Journal of Men’s Health, 12, 160–71.Google Scholar
Kivimäki, M., Pentti, J., Ferrie, J. E., et al. 2018. Work stress and risk of death in men and women with and without cardiometabolic disease: a multicohort study. Lancet Diabetes Endocrinology, 6(9), 705–13.Google Scholar
Knapen, J., Vancampfort, D., Moriën, Y., et al. 2015. Exercise therapy improves both mental and physical health in patients with major depression. Disability and Rehabilitation, 37, 1490–5.Google Scholar
Ladwig, K. H., Baumert, J., Marten-Mittag, B., et al. 2017. Room for depressed and exhausted mood as a risk predictor for all-cause and cardiovascular mortality beyond the contribution of the classical somatic risk factors in men. Atherosclerosis, 257, 224–31.Google Scholar
Latvala, A., Kuja-Halkola, R., Rück, C., et al. 2016. Association of resting heart rate and blood pressure in late adolescence with subsequent mental disorders: a longitudinal population study of more than 1 million men in Sweden. JAMA Psychiatry, 73, 1268–75.Google Scholar
Lee, C., Oliffe, J. L., Kelly, M. T., et al. 2017. Depression and suicidality in gay men: implications for health care providers. American Journal of Men’s Health, 11, 910–19.Google Scholar
Lichtman, J. H., Froelicher, E. S., Blumenthal, J. A., et al. 2014. Depression as a risk factor for poor prognosis among patients with acute coronary syndrome: systematic review and recommendations: a scientific statement from the American Heart Association. Circulation, 129, 1350–69.Google Scholar
Lichtman, J. H., Bigger, J. T. Jr., Blumenthal, J. A., et al. 2008. Depression and coronary heart disease: recommendations for screening, referral, and treatment: a science advisory from the American Heart Association Prevention Committee of the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdisciplinary Council on Quality of Care and Outcomes Research: rendorsed by the American Psychiatric Association. Circulation, 118, 1768–75.Google Scholar
Lloyd, C. E., Nouwen, A., Satorius, N., et al. 2018. Prevalence and correlates of depressive disorders in people with Type 2 diabetes: results from the International Prevalence and Treatment of Diabetes and Depression (INTERPRET-DD) study, a collaborative study carried out in 14 countries. Diabetic Medicine, 35, 760–9.Google Scholar
Martin, L. A., Neighbors, H. W., and Griffith, D. M. 2013. The experience of symptoms of depression in men vs women. Analysis of the National Comorbidity Survey Replication. JAMA Psychiatry, 70, 1100–6.Google Scholar
Mensah, G. A. and Collins, P. Y. 2015. Understanding mental health for the prevention and control of cardiovascular diseases. Global Heart, 10, 221–4.Google Scholar
Naci, H. and Ioannidis, J. P. 2013. Comparative effectiveness of exercised and drug interventions on mortality outcomes: metaepidemiological study. BMJ, 347, f5577.Google Scholar
Nielsen, T. J., Vestergaard, M., Fenger-Grøn, M., et al. 2015. Healthcare contacts after myocardial infarction according to mental health and socioeconomic position: a population-based cohort study. PLoS One, 10(7), e0134557.Google Scholar
Norlund, F., Lissåker, C., Wallert, J., et al. 2018. Factors associated with emotional distress in patients with myocardial infarction: results from the SWEDEHEART registry. European Journal of Preventive Cardiology, 25, 910–20.CrossRefGoogle ScholarPubMed
Pedersen, S. S., von Känel, R., Tully, P. J., et al. 2017. Psychosocial perspectives in cardiovascular disease. European Journal of Preventive Cardiology, 24, 108–15.Google Scholar
Peters, D., Deady, M., Gloziet, N., et al. 2018. Worker preferences for a mental health app within male-dominated industries: participatory study. JMIR Mental Health, 5(2), e30.Google Scholar
Piano, M. R., Burke, L., Kang, M., et al. 2018. Effects of repeated binge drinking on blood pressure and other cardiovascular health metrics in young adults: National Health and Nutrition Examination Survey, 2011–2014. Journal of the American Heart Association, 7, e008733.Google Scholar
Piepoli, M. F., Hoes, A. W., Agewall, S., et al. 2016. 2016 European guidelines on cardiovascular disease prevention in clinical practice. The Sixth Joint task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts). Developed with the special contribution of the European Association for Cardiovascular Prevention and Rehabilitation (EAPCR). European Heart Journal, 37, 2315–81.Google Scholar
Potjik, M. R., Janszky, I., Reijneveld, S. A., et al. 2015. Risk of coronary heart disease in men with poor emotional control: a prospective study. Psychosomatic Medicine, 78, 60–7.Google Scholar
Richards, D. A., Ekers, D., McMillan, D., et al. 2016. Cost and outcome of behavioural activation versus cognitive behavioural therapy for depression (COBRA): a randomised, controlled, non-inferiority trial. Lancet, 388, 871–80.Google Scholar
Richards, S. H., Anderson, L., Jenkinson, C. E., et al. 2018. Psychological interventions for coronary heart disease: Cochrane systematic review and meta-analysis. European Journal of Preventive Cardiology, 25, 247–59.Google Scholar
Ruitenberg, A., Ott, A., van Swieten, J. C., et al. 2001. Incidence of dementia: does gender make a difference? Neurobiology of Aging, 22, 575–80.Google Scholar
Seidler, Z. E., Dawes, A. J., Rice, S. M., et al. 2016. The role of masculinity in men’s help-seeking for depression: a systematic review. Clinical Psychology Review, 49, 106–18.Google Scholar
Senaratna, C. V., English, D. R., Currier, D., et al. 2016. Sleep apnoea in Australian men: disease burden, co-morbidities, and correlates from the Australian longitudinal study on male health. BMC Public Health, 16 (suppl. 3), 1029.Google Scholar
Ski, C. F., Worrall-Carter, L., Cameron, J., et al. 2017. Depression screening and referral in cardiac wards: a 12-month patient trajectory. European Journal of Cardiovascular Nursing, 16, 157–66.Google Scholar
Steel, Z., Marnane, C., Iranpour, C., et al. 2014. The global prevalence of common mental disorders: a systematic review and meta-analysis 1980–2013. International Journal of Epidemiology, 43, 476–93.Google Scholar
Strid, C., Andersson, C., and Öjehagen, A. 2017. The influence of hazardous drinking on psychological functioning, stress and sleep during and after treatment in patients with mental health problems; a secondary analysis of a randomised controlled intervention study. BMJ Open, 8, e019128.Google Scholar
Tully, P. J., Harrison, N. J., Cheung, P., et al. 2016. Anxiety and cardiovascular disease risk: a review. Current Cardiology Reports, 18, 120.Google Scholar
Tully, P. J., Sardhina, A., and Nardi, A. E. 2016. A new CBT model of Panic Attack Treatment in Comorbid Heart Diseases (PATCHD): how to calm an anxious heart and mind. Cognitive Behavioral Practice, 24, 329–41.Google Scholar
Vancampfort, D., Firth, J., Schuch, F. B., et al. 2017. Sedentary behavior and physical activity levels in people with schizophrenia, bipolar disorder and major depressive disorder: a global systematic review and meta‐analysis. World Psychiatry, 16, 308–15.Google Scholar
Walker, E. R., McGee, R. E., and Druss, B. G. 2015. Mortality in mental disorders and global disease implications: a systematic review and meta-analysis. JAMA Psychiatry, 72, 334–41.Google Scholar
Weinstein, G., Lutski, M., Goldbourt, U., et al. 2018. Physical frailty and cognitive function among men with cardiovascular disease. Archives of Gerontology and Geriatrics, 78, 16.CrossRefGoogle ScholarPubMed
Westermair, A. L., Schaich, A., Willenborg, B., et al. 2018. Utilization of mental health care, treatment patterns, and course of psychosocial functioning in Northern German coronary artery disease patients with depressive and/or anxiety disorders. Frontiers in Psychiatry, 9, 75.Google Scholar
World Health Organization. 2014. Preventing Suicide: A Global Imperative. Geneva: WHO.Google Scholar
World Health Organization. 2018a. Fact Sheets: Cardiovascular Diseases. Geneva: WHO.Google Scholar
World Health Organization. 2018b. Fact Sheets: Depression. Geneva: WHO.Google Scholar
Ziegelstein, R. C., Thombs, B. D., Coyne, J. C., et al. 2009. Routine screening for depression in patients with coronary heart disease: never mind. Journal of the American College of Cardiology, 54, 886–90.Google Scholar

References

Bachem, R. and Casey, P. 2017. Adjustment disorders: a diagnosis whose time has come. Journal of Affective Disorders, 227, 243–53.Google Scholar
Bobevski, I., Kissane, D. W., Vehling, S., et al. 2018. Latent class analysis differentiation of adjustment disorder and demoralization, more severe depressive-anxiety disorders, and somatic symptoms in a cohort of patients with cancer. Psycho-Oncology. 27(11), 2623–30. doi:10.1002/pon.4761Google Scholar
Cancer Council of Australia. 2016. Understanding Testicular Cancer. Accessed at www.cancer.org.au/about-cancer/types-of-cancer/testicular-cancer.html.Google Scholar
Cornish, J. A., Tilnet, H. S., Heriot, A. G., Lavery, I. C., Fazio, V. W., and Tekkis, P. P. 2007. A meta-analysis of quality of life for abdominoperitoneal excision of rectum versus anterior resection for rectal cancer. Annals of Surgical Oncology, 14, 2056–68.Google Scholar
Faller, H., Schuler, M., Richard, M., Heckl, U., Weis, J., and Küffner, R. 2013. Effects of psycho-oncologic interventions on emotional distress and quality of life in adult patients with cancer: systematic review and meta-analysis. Journal of Clinical Oncology, 31, 782–93.Google Scholar
Fujisawa, D. and Uchitomi, Y. 2017. Depression in Cancer Care. In: Watson, M. and Kissane, D. W. (eds.) Management of Clinical Anxiety and Depression. 2341. Oxford: Oxford University Press.Google Scholar
Glaesmer, H., Romppel, M., Brahler, E., Hinz, A., et al. 2015. Adjustment disorder as proposed for ICD-11: dimensionality and symptom differentiation. Psychiatry Research, 229, 940–8.Google Scholar
Hart, S. L., Hoyt, M. A., Diefenbach, M., et al. 2012. Meta-analysis of efficacy of interventions for elevated depressive symptoms in adults diagnosed with cancer. Journal of National Cancer Institute, 104, 9901004.Google Scholar
Horner, D. J., Wendel, C. S., Skeps, R., et al. 2010. Positive correlation of employment and psychological well-being for veterans with major abdominal surgery. American Journal of Surgery, 200, 585–90.Google Scholar
Karl, A., Buchner, A., Becker, A., et al. 2014. A new concept for early recovery after surgery for patients undergoing radical cystectomy for bladder cancer: results from a prospective randomized study. Journal of Urology, 191, 335–40.Google Scholar
Kissane, D. W., Miach, P., Bloch, S., Seddon, A., and Smith, G. C. 1997. Cognitive-existential group therapy for patients with primary breast cancer. Psycho-Oncology, 6, 2533.Google Scholar
Kissane, D. W. and Bloch, S. 2002. Family Focused Grief Therapy: A Model of Family-Centred Care during Palliative Care and Bereavement. Buckingham: Open University Press.Google Scholar
Kissane, D. W. 2012. The relief of existential suffering. Archives of Internal Medicine, 172(19), 1501–5.Google Scholar
Kissane, D. W. 2014. Unrecognised and untreated depression in cancer care. The Lancet Psychiatry, 1(5), 320–1.Google Scholar
Kissane, D. W. 2014. Demoralization – A life-preserving diagnosis to make in the severely medically ill. Journal of Palliative Care, 30, 255–8.Google Scholar
Kissane, D. W., Bobevski, I., Gaitanis, P., et al. 2017. Exploratory examination of the utility of demoralization as a specifier for adjustment disorder and major depression. General Hospital Psychiatry, 46, 20–4.Google Scholar
Kissane, D. W., Patel, S. G., Baser, R. E., et al. 2013. Preliminary evaluation of the reliability and validity of the shame and stigma scale in head and neck cancer. Head and Neck, 35, 172–83.Google Scholar
Krebber, A. M., Leemans, C. R., de Bree, R., et al. 2012. Stepped care targeting psychological distress in head and neck and lung cancer patients: a randomized clinical trial. BMC Cancer, 12, 18.Google Scholar
Krouse, R. S., Grant, M., Wendel, C. S., et al. 2007. A mixed-methods evaluation of health-related quality of life for male veterans with and without intestinal stomas. Disease of Colon and Rectum, 50, 2054–66.Google Scholar
Krouse, R. S., Grant, M., Rawl, S. M., et al. 2009. Coping and acceptance: the greatest challenge for veterans with intestinal stomas. Journal of Psychosomatic Research, 66, 227–33.Google Scholar
Lederberg, M. S., Holland, J. C. 2011. Supportive psychotherapy in cancer care: an essential ingredient of all therapy. In: Watson, M. and Kissane (eds.), D. W. Handbook of Psychotherapy in Cancer Care. 314. Chichester: Wiley-Blackwell.Google Scholar
Li, M., Rosenblat, J., and Rodin, G. 2017. Psychopharmacologic management of anxiety and depression. In: Watson, M. and Kissane (eds.), D. W. Management of Clinical Anxiety and Depression. 78107. Oxford: Oxford University Press.Google Scholar
Manne, S. L., Kissane, D. W., Nelson, C. J., Mulhall, J. P., Winkel, G., and Zaider, T. 2011. Intimacy-enhancing psychological intervention for men diagnosed with prostate cancer and their partners: a pilot study. Journal of Sexual Medicine 8(4), 11971209.Google Scholar
Mausbach, B. T., Schwab, R. B., and Irwin, S. A. 2015. Depression as a predictor of treatment adherence to adjuvant endocrine therapy (AET) in women with breast cancer: a systematic review and meta-analysis. Breast Cancer Research and Treatment, 152, 239–46.Google Scholar
Mehnert, A., Brahler, E., Faller, H., et al. 2014. Four-week prevalence of mental disorders in patients with cancer across major tumor entities. Journal of Clinical Oncology, 32, 3540–6.Google Scholar
Moorey, S. and Greer, S. 2012. Oxford Guide to CBT for People with Cancer. Oxford: Oxford University Press.Google Scholar
Pachler, J. and Wille-Jorgensen, P. 2005. Quality of life after rectal resection for cancer, with or without permanent colostomy. Cochrane Database Systematic Review, CD004323.Google Scholar
Pinquart, M. and Duberstein, P. R. 2010. Depression and cancer mortality: a meta-analysis. Psychological Medicine, 40, 17971810.Google Scholar
Poch, M. A., Stegemann, A. P., and Rehman, S., et al. 2013. Short-term patient reported health-related quality of life (HRQL) outcomes after robot-assisted radical cystectomy. British Journal of Urology International, 113, 260–5.Google Scholar
Satin, J. R., Linden, W., and Phillips, M. J. 2009. Depression as a predictor of disease progression and mortality in cancer patients. Cancer, 115, 5349–61.Google Scholar
Schuler, T. A., Zaider, T. I., and Kissane, D. W. 2012. Family grief therapy: a vital model in oncology, palliative care and bereavement. Family Matters, 90, 7786.Google Scholar
Semple, C., Parahoo, K., Norman, A., et al. 2013. Psychosocial interventions for patients with head and neck cancer. Cochrane Database Systematic Review, CD009441.Google Scholar
Sharpe, M., Walker, J., Hansen, C. H., et al. 2014. Integrated collaborative care for comorbid major depression in patients with cancer (SMaRT Oncology-2): a multicentre randomised controlled effectiveness trial. Lancet, 384, 10991108.Google Scholar
Skeppner, E., Windahl, T., Andersson, S. O., Fugl-Meyer, K. S. 2008. Treatment-seeking, aspects of sexual activity and life satisfaction in men with penile carcinoma. European Urology, 54, 631–9.Google Scholar
Skoogh, J., Steineck, G., Johansson, B., Wilderang, U., and Stierner, U. 2013. Psychological needs when diagnosed with testicular cancer: findings from a population-based study with long-term follow-up. British Journal of Urology International, 111, 1287–93.Google Scholar
Sun, V., Grant, M., McMullen, C. K., et al. 2013. Surviving colorectal cancer: long-term, persistent ostomy-specific concerns and adaptations. Journal of Wound Ostomy, 40, 6172.Google Scholar
Vennix, S., Pelzers, L., Bouvy, N., et al. 2014. Keyhole laparoscopic or open surgery for rectal cancer. Cochrane Database of Systematic Reviews, CD005200.Google Scholar
Walker, J., Holm Hansen, C., Martin, P., et al. 2014. Integrated collaborative care for major depression comorbid with a poor prognosis cancer (SMaRT Oncology-3): a multicentre randomised controlled trial in patients with lung cancer. Lancet Oncology, http://dx.doi.org/10.1016/S1470-2045(14)70343-2.Google Scholar
Yalom, I. D. 1980. Existential Psychotherapy. New York: Basic Books.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×